Answers are grounded in this paper and cite their sources.
A new generation of photothermal theranostic agents is developed based on PEGylated WS2 nanosheets. Bimodal in vivo CT/photoacoustic imaging reveals strong tumor contrast after either intratumoral or intravenous injection of WS2 -PEG. In vivo photothermal treatment is then conducted in a mouse tumor model, achieving excellent therapeutic efficacy with complete ablation of tumors. This work promises further exploration of transition-metal dichalcogenides for biomedical applications, such as cancer imaging and therapy.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: